MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy

World Journal of Urology, 05/02/2011

MRI–guided biopsy (MR–GB) shows a high detection rate of clinically significant PCa in patients with previous negative trans–rectal–ultrasound–guided biopsy (TRUS–GB) and persisting suspicion for Prostate cancer (PCa). In univariate regression analysis, only serum prostate specific antigen (PSA) levels were predictive for a positive biopsy result. Number of preceding negative biopsies was not associated with the likelihood of a positive biopsy result

Print Article Summary Cat 2 CME Report